CDK8 remodels the tumor microenvironment and promotes resistance to KRAS(G12D) inhibitors and daraxonrasib in PDAC. (link.springer.com)

Authors: McAndrews KM … Kalluri R Journal: The EMBO Journal Published: 2026-07-11 DOI: https://doi.org/10.1038/s44318-026-00854-5